SEC Filings for Outlook Therapeutics Inc. (OTLK)

$ 1.22 r      0.06 (+5.17%) Volume: 2.05m 4:00 PM EDT 4-Jun-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
424B3Prospectus [Rule 424(b)(3)]205/29/2020
8-KCurrent report pursuant to Section 13 or 15(d)3705/28/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans7705/15/2020
8-KCurrent report pursuant to Section 13 or 15(d)1005/15/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)5105/15/2020
8-KCurrent report pursuant to Section 13 or 15(d)305/11/2020
4Statement of changes in beneficial ownership of securities104/21/2020
3Initial statement of beneficial ownership of securities204/21/2020
8-KCurrent report pursuant to Section 13 or 15(d)304/21/2020
3Initial statement of beneficial ownership of securities204/21/2020
4Statement of changes in beneficial ownership of securities104/21/2020
4Statement of changes in beneficial ownership of securities104/21/2020
4Statement of changes in beneficial ownership of securities104/21/2020
8-KCurrent report pursuant to Section 13 or 15(d)704/17/2020
<<
First
<
Prev
123456789101112131415